Related Experiment Video

Updated: Aug 1, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Hypertrophy to failure

P H Tanser

    Journal of Human Hypertension
    |September 1, 1994
    PubMed

    Insights

    Left ventricular hypertrophy (LVH) is a serious heart condition linked to hypertension. Angiotensin converting enzyme (ACE) inhibitors show the most promise in reversing LVH compared to other antihypertensive drugs.

    Area of Science:

    • Cardiology
    • Hypertension Research
    • Cardiac Pathophysiology

    Background:

    • Left ventricular hypertrophy (LVH) is a common outcome of hypertension and a significant predictor of cardiovascular events.
    • Pathological LVH involves myocyte and nonmyocyte cellular changes within the myocardium, often exacerbated by hormonal factors like Angiotensin II and aldosterone.
    • While hypertension management has reduced LVH incidence, the choice of antihypertensive medication impacts LVH reversal and heart failure development.

    Purpose of the Study:

    • To review the impact of antihypertensive therapies on the reversal of left ventricular hypertrophy.
    • To compare the efficacy of different antihypertensive drug classes in reducing LVH.
    • To identify optimal therapeutic strategies for managing LVH in hypertensive patients.

    Main Methods:

    • Literature review and meta-analysis of clinical trials examining antihypertensive treatments and LVH.
    • Echocardiography used to assess left ventricular mass index and wall thickness for LVH determination.
    • Analysis of studies comparing the effects of Angiotensin converting enzyme (ACE) inhibitors, beta-blockers, and calcium channel blockers on LVH reversal.

    Main Results:

    • Angiotensin converting enzyme (ACE) inhibitors, beta-blockers, and calcium channel blockers are effective in rapidly reversing LVH.
    • Meta-analysis indicates a potential advantage of ACE inhibitors over other antihypertensive classes in promoting LVH reversal.
    • The choice of antihypertensive therapy significantly influences the rate of LVH regression and subsequent heart failure risk.

    Conclusions:

    • Early hypertension diagnosis and treatment are crucial for decreasing LVH and heart failure.
    • Angiotensin converting enzyme (ACE) inhibitors may offer superior benefits for LVH reversal compared to other antihypertensive agents.
    • Tailoring antihypertensive therapy is essential for optimizing LVH management and cardiovascular outcomes.

    More Related Videos

    A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure06:47

    A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

    Published on: November 29, 2018

    Magnetic Adjustment of Afterload in Engineered Heart Tissues09:40

    Magnetic Adjustment of Afterload in Engineered Heart Tissues

    Published on: May 5, 2020

    Related Concept Videos

    Muscle Recovery and Fatigue01:24

    Muscle Recovery and Fatigue

    Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
    Fatigue01:21

    Fatigue

    Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Cellular Adaptation I: Introduction and Atrophy01:23

    Cellular Adaptation I: Introduction and Atrophy

    Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
    Cellular Adaptation II: Hypertrophy01:26

    Cellular Adaptation II: Hypertrophy

    Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
    Cellular Adaptation III: Hyperplasia01:26

    Cellular Adaptation III: Hyperplasia

    Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...